Rod S. Daniels

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Influenza Surveillance in the Central African Republic From 2015 to 2018 to Inform Vaccination and Treatment Strategies.

Influenza Surveillance in the Central African Republic From 2015 to 2018 to Inform Vaccination and Treatment Strategies.

Journal: Influenza and other respiratory viruses

Published: August 16, 2025

Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.

Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.

Journal: Antiviral research

Published: January 14, 2025

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.

Journal: Antiviral research

Published: December 14, 2021

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.

Journal: Antiviral research

Published: November 22, 2019

Association of Increased Receptor-Binding Avidity of Influenza A(H9N2) Viruses with Escape from Antibody-Based Immunity and Enhanced Zoonotic Potential.

Association of Increased Receptor-Binding Avidity of Influenza A(H9N2) Viruses with Escape from Antibody-Based Immunity and Enhanced Zoonotic Potential.

Journal: Emerging infectious diseases

Published: December 19, 2018

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.

Journal: Antiviral research

Published: April 17, 2018

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.

Journal: Antiviral research

Published: April 10, 2017

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Journal: Antiviral research

Published: April 11, 2016

Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.

Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 25, 2016

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

Journal: Antiviral research

Published: November 24, 2014

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.

Journal: Antiviral research

Published: May 21, 2014

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.

Journal: Vaccine

Published: December 04, 2013

Showing 1-12 of 21

Last Updated: 09/26/2026